LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p

BACKGROUND: Cisplatin is the most commonly used chemotherapy drug in clinical settings, and decreased sensitivity or resistance to cisplatin is the main cause of chemotherapy failure or death among cancer patients. Long non-coding RNA (lncRNA) SNHG1 is highly expressed in non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lei, Yang, Nan, Sun, Lei, Zhang, Lei, Li, Zhongdong, Li, Demin, Qin, Tao, Huang, Hairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798157/
https://www.ncbi.nlm.nih.gov/pubmed/35116964
http://dx.doi.org/10.21037/tcr.2019.09.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798157/
https://www.ncbi.nlm.nih.gov/pubmed/35116964
http://dx.doi.org/10.21037/tcr.2019.09.24

Ejemplares similares